Why Immunise

06/07/2022

https://whyimmunise.com/news/global-regulators-agree-on-key-principles-on-adapting-vaccin/

On 30 June, regulators from around the world discussed emerging evidence to support adaptation of COVID-19 vaccines as the SARS-COV-2 virus continues to

29/06/2022

https://whyimmunise.com/news/amref-and-astrazeneca-launch-clinics-to-support-kenyan-covid/

The mobile clinics will support communities with limited or no access to vaccines and other health servicesAmref Health Africa and

17/08/2021

https://whyimmunise.com/news/telemedicine-may-not-work-for-speech-voice-therapy/

MONDAY, Aug. 9, 2021 (HealthDay News) Telemedicine may fall short when it comes to people with voice and speech disorders, researchers report. There was a

03/08/2021

https://whyimmunise.com/news/covid-19-vaccine-spikevax-approved-for-children-aged-12-to-1/

EMA’s human medicines committee (CHMP) has recommended granting an extension of indication for the COVID-19 vaccine Spikevax (previously COVID-19 Vaccine

19/07/2021

https://whyimmunise.com/news/artificial-intelligence-could-be-new-blueprint-for-precision/

Writing in the July 12, 2021 online issue of Nature Communications, researchers at University of California San Diego School of Medicine describe a new

24/06/2021

https://whyimmunise.com/news/is-respiratory-syncytial-virus-rsv-contagious/

Is respiratory syncytial virus (RSV) contagious? Respiratory syncytial virus (RSV) is contagious. In the United States, it's the most common cause of

21/06/2021

https://whyimmunise.com/news/annual-report-2020-published-european-medicines-agency/

EMA has published today its 2020 annual report that provides an overview of the Agency’s major achievements and contributions to public health in

04/06/2021

https://whyimmunise.com/news/

x

27/05/2021

26/05/2021

https://whyimmunise.com/news/mans-robotic-arm-works-faster-with-high-tech-sense-of-touch/

Latest Prevention & Wellness News By Dennis Thompson HealthDay Reporter MONDAY, May 24, 2021 (HealthDay News) The robot hand extends toward

10/05/2021

EMA starts rolling review of COVID-19 Vaccine (Vero Cell) Inactivated

https://whyimmunise.com/news/ema-starts-rolling-review-of-covid-19-vaccine-vero-cell-in/

EMA’s human medicines committee (CHMP) has started a rolling review of COVID-19 Vaccine (Vero Cell) Inactivated, developed by Sinovac Life Sciences Co.,

26/04/2021

COVID-19 Vaccine AstraZeneca: benefits still outweigh the risks despite possible link to rare blood clots with low blood platelets

https://whyimmunise.com/news/covid-19-vaccine-astrazeneca-benefits-still-outweigh-the-ri/

EMA’s safety committee, PRAC, concluded its preliminary review of a signal of blood clots in people vaccinated with COVID-19 Vaccine AstraZeneca at its

19/02/2021

Latest news from WhyImmunise.com
Pfizer and BioNTech commence global clinical trial to evalua& #8230;
Read more: https://whyimmunise.com/news/pfizer-and-biontech-commence-global-clinical-trial-to-evalua/

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the first participants have been dosed in a global Phase 2/3 study to further

07/02/2021

The what why and how of immunisation.

https://whyimmunise.com/comingsoon/

The what, why's and how's - A resource for information surrounding immunisations.